19 May 2013
Keywords: novadel, anxiolytic, mouth, spray, promising, pk, data
Article | 16 May 2005
The USA's NovaDel Pharma has posted strong results from a pilot pharmacokinetic trial of its proprietary lingual spray delivering
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 May 2005
17 May 2013
© 2013 thepharmaletter.com